por
Lynn Shapiro, Writer | January 20, 2009
Another round in
a long court skirmish
Johnson & Johnson said The Court of Appeals for the Federal Circuit in Washington, D.C., has found Boston Scientific Corporation's Ding stent patent invalid, and has reversed a 2005 jury decision finding that J&J's Cypher-Sirolimus-eluting stent infringed on Boston's patent.
The original jury verdict was rendered in July 2005 in Wilmington, Delaware. Boston Scientific had claimed that its Ding patent covered a two-layer drug coating for its stent, which the Appeals Court found to be "obvious" in light of earlier-issued patents, J&J said.
In the same court, Boston Scientific is appealing a $703 million judgment against J&J, after a jury found that several of Boston's stents infringed on J&J patents. J&J's Cordis unit makes its stents.
Ad Statistics
Times Displayed: 14669
Times Visited: 254 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
